Partner Content Partner Content PRISYM ID announces six further projects go live PRISYM ID has six new labeling software systems
Partner Content Partner Content Foods, supplements, and medicine: the new frontier in chroni... Chronic diseases are the biggest threat to our global socio-economic development.
Partner Content Partner Content 3 Considerations for Pharma Brand Strategy Success How to reach the right people - with or without cookies
Partner Content Partner Content Continuity of Care in a Pandemic: Reflecting on the Rise of ... Health Union research shows telehealth use has tripled
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
